Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

65 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Protracted coronavirus disease 2019 after chimeric antigen receptor-T cell therapy successfully treated with sequential multidrug therapy.
Yamashita M, Higo H, Fujii N, Matsumoto C, Makimoto G, Ninomiya K, Fujii M, Rai K, Ichihara E, Ohashi K, Hotta K, Tabata M, Maeda Y, Miyahara N. Yamashita M, et al. Among authors: makimoto g. Respir Med Case Rep. 2024 Sep 2;51:102104. doi: 10.1016/j.rmcr.2024.102104. eCollection 2024. Respir Med Case Rep. 2024. PMID: 39286407 Free PMC article.
A Case of Single-lung Transplant in a Patient with Mycobacterium avium Pulmonary Disease Successfully Treated with Amikacin Liposome Inhalation Suspension.
Ozeki T, Higo H, Omori H, Mori S, Tanaka S, Makimoto G, Ninomiya K, Taniguchi A, Fujii M, Miyoshi K, Rai K, Ichihara E, Ohashi K, Sugimoto S, Hotta K, Tabata M, Toyooka S, Maeda Y, Miyahara N. Ozeki T, et al. Among authors: makimoto g. Intern Med. 2024 Sep 11. doi: 10.2169/internalmedicine.3854-24. Online ahead of print. Intern Med. 2024. PMID: 39261070 Free article.
A randomized, open-label phase II study on the preventive effect of goshajinkigan against peripheral neuropathy induced by paclitaxel-containing chemotherapy: The OLCSG2101 study protocol.
Nakamura N, Makimoto G, Tanaka T, Kato Y, Oze I, Kozuki T, Yokoyama T, Ichikawa H, Kuyama S, Hara N, Maeda Y, Hotta K. Nakamura N, et al. Among authors: makimoto g. Respir Investig. 2024 Sep;62(5):897-900. doi: 10.1016/j.resinv.2024.07.017. Epub 2024 Aug 7. Respir Investig. 2024. PMID: 39182943
Concomitant osimertinib and antituberculosis therapy in an elderly patient with EGFR-mutated lung cancer and pulmonary tuberculosis: A case report.
Matsuura H, Higo H, Kuribayashi T, Tamaoki A, Nakasuka T, Uno M, Makimoto G, Ninomiya K, Fujii M, Rai K, Ichihara E, Hotta K, Miyahara N, Tabata M, Maeda Y, Kiura K, Ohashi K. Matsuura H, et al. Among authors: makimoto g. Thorac Cancer. 2024 Jun;15(17):1390-1394. doi: 10.1111/1759-7714.15324. Epub 2024 May 2. Thorac Cancer. 2024. PMID: 38698706 Free PMC article.
A Prompt Diagnosis and Treatment of a Case of Nuclear Protein of the Testis Carcinoma Characterized by a Bronchial Lesion and High Serum Alpha-fetoprotein Level Following Genomic Testing.
Matsuura H, Makimoto G, Oda N, Ninomiya K, Higo H, Fujii M, Rai K, Ichihara E, Ohashi K, Hotta K, Tabata M, Maeda Y. Matsuura H, et al. Among authors: makimoto g. Intern Med. 2024 Oct 1;63(19):2655-2660. doi: 10.2169/internalmedicine.2938-23. Epub 2024 Feb 26. Intern Med. 2024. PMID: 38403772 Free PMC article.
Effectiveness and safety of primary prophylaxis with G-CSF for lung cancer: a systematic review and meta-analysis to develop clinical practice guidelines for the use of G-CSF 2022.
Ichihara E, Ochi N, Makimoto G, Kudo K, Harada D, Ozaki Y, Nishio H, Tsuchihashi K, Miura Y, Endo M, Yano S, Maruyama D, Yoshinami T, Susumu N, Takekuma M, Motohashi T, Ito M, Baba E, Uchino K, Kimura T, Kamiyama Y, Nakao S, Tamura S, Nishimoto H, Kato Y, Sato A, Takano T, Kubo T. Ichihara E, et al. Among authors: makimoto g. Int J Clin Oncol. 2024 Apr;29(4):355-362. doi: 10.1007/s10147-024-02469-4. Epub 2024 Feb 14. Int J Clin Oncol. 2024. PMID: 38353907
65 results